|
From
APIs to ABIs
Indian pharmaceutical companies are gearing up to capture
a major chunk of the biogenerics market. The pickings are
bound to be good, but managing active biological ingredients
(ABIs) is not as simple as active pharmaceutical ingredients
(APIs). Viveka Roychowdhury explores the strategies at work
'We
know what combination to offer to patients'
Charak Pharma is perhaps the only ayurvedic company that has
introduced the unique concept of 'Charak Clinics'. It's natural
and pure healing methods have made them one of the most sought
after treatment centres for those who want to heal Chronic
Diseases naturally. Sachin Jagdale explores more in an interview
with Pulin Shroff, Managing Director, Charak Pharma
'Clients
have come to expect high quality products with superior performance'
Ankur Chokshi, Sales Director - South Asia and Subodh Priolkar,
General Manager - South Asia, Colorcon reveal their market
strategy to Express Pharma
Not
just another brick in the wall
As Bilcare Clinical Research enters into its fifth month of
operations, Santosh Hegde, President, Clinical Research Services,
Bilcare talks to Garima Arora about what sets the institute
apart from the rest
Intas
Pharma wins Animal Pharm Global Excellence Award
Intas Pharma has won the Animal Pharm Global Excellence Awards
for the year 2007, for unique initiatives in the area of Corporate
Social Responsibility (CSR).
Electrolab
announces successful online connectivity with HPLC
Drug development and analysis in today's pharma industry works
in conjunction with the dissolution tester, while identification
of drug is done with analytical instruments through spectrophotometry,
HPLC, etc.
Educe
Solutions associates with ICH M2 group
Educe Solutions, a Pune-based software product development
company providing software solutions to the pharmaceutical
vertical and has developed Dossier-Mgmt© an e-CTD software
for electronic submissions, is formally associating itself
with ICH M2 group, an international organisation responsible
for e-CTD specifications.
Colorcon
acquires division of Chr Hansen
Colorcon recently announced the acquisition of the pharma
excipients and coating division of Chr Hansen. This acquisition
expands Colorcon's global product offerings in the pharma
and nutritional markets.
'Pharma
the most happening industry vertical for us'
With pharma companies investing heavily in core activities
such as drug R&D and marketing, non-core functions like
procurement logistics and product distribution are outsourced.
But because these functions are essential links in the pharma
value chain, they need 'safe' handling. In an interview with
Express Pharma, Safexpress's Chairman, Pawan Jain describes
how his company has designed customised logistics services
for pharma companies
|
